Sales Ended

Life Sciences Investor Briefing with CEO’s from Destiny Pharma, Open Orphan, the CFO from Shield Therapeutics and the Head of Life Sciences at Hardman & Co.


Follow this organiser to stay informed on future events

By London South East - LSE.co.uk